title: From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists.
abstract: Metoclopramide is a stimulant of upper gut motility and an anti-emetic. The mechanisms by which the drug exerts these actions has been the subject of considerable research, which is briefly reviewed in this article. From the viewpoint of drug discovery, the properties of metoclopramide have directly led to the development of selective gut motility stimulants and 5-HT3 receptor antagonists. These events and the potential clinical use of such compounds are reviewed in detail.
authors.affiliation: Beecham Pharmaceuticals Research Division, Harlow, Essex, UK.
authors.forename: G J
authors.initials: GJ
authors.lastname: Sanger
authors.forename: F D
authors.initials: FD
authors.lastname: King
mesh_terms: D000818:Animals; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D008787:Metoclopramide / Q000494:pharmacology*; D011985:Receptors, Serotonin / Q000187:drug effects*; D012702:Serotonin Antagonists / Q000494:pharmacology*
chemical_list: D005765:Gastrointestinal Agents; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D008787:Metoclopramide